Publications | Lund University Publications

631 – 640 of 659

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/publication?embed=1&q=department+exact+V1000575&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

1998
Mark Continuous infusion of factor IX concentrate to induce immune tolerance in two patients with haemophilia B
Tengborn, Lilian ^LU and Berntorp, Erik ^LU (1998) In Haemophilia 4(1). p.56-59
- Contribution to journal › Article
Mark The A20210 allele of the prothrombin gene is frequently associated with the factor V Arg 506 to Gln mutation but not with protein S deficiency in thrombophilic families
Zöller, Bengt ^LU ; Svensson, P J ^LU ; Dahlbäck, Björn ^LU and Hillarp, A ^LU (1998) In Blood 91(6). p.1-2210
- Contribution to journal › Letter
Mark The A20210 allele of the prothrombin gene is frequently associated with the factor V Arg 506 to Gln mutation but not with protein S deficiency in thrombophilic families [3]
Zöller, Bengt ^LU ; Svensson, P.J. ^LU ; Dahlbäck, Björn ^LU and Hillarp, A. ^LU (1998) In Blood 91(6). p.2210-2211
- Contribution to journal › Letter
1997
Mark No effect of a new second-generation B-domain-deleted recombinant product on lymphocyte transformation in vitro: a study of plasma-derived and recombinant products
Astermark, Jan ^LU ; Ekman, Maj ^LU and Berntorp, Erik ^LU (1997) In British Journal of Haematology 99(2). p.289-294
- Contribution to journal › Article
Mark Age relations of cardiovascular risk factors in a traditional Melanesian society: the Kitava Study
Lindeberg, Staffan ^LU ; Berntorp, Erik ^LU ; Nilsson-Ehle, Peter ^LU ; Terent, Andreas and Vessby, Bengt (1997) In American Journal of Clinical Nutrition 66(4). p.845-852
- Contribution to journal › Article
Mark Pharmacokinetic dosing of factor VIII and factor IX in prophylactic treatment of haemophilia
Carlsson, Maj ^LU (1997)
- Thesis › Doctoral thesis (compilation)
Mark Resistance to activated protein C a novel risk factor for venous thrombosis
Svensson, Peter ^LU (1997)
- Thesis › Doctoral thesis (compilation)
Mark Improved cost-effectiveness by pharmacokinetic dosing of factor VIII in prophylactic treatment of haemophilia A
Carlsson, M ; Berntorp, E. ^LU ; Björkman, S ; Lethagen, S. ^LU and Ljung, R. ^LU (1997) In Haemophilia 3(2). p.96-101
- Contribution to journal › Article
Mark The factor VR5O6Q mutation causing APC resistance is highly prevalent amongst unselected outpatients with clinically suspected deep venous thrombosis
Svensson, P.J. ^LU ; Zöller, B. ^LU ; Mattiasson, I. ^LU and Dahlbäck, B. ^LU (1997) In Journal of Internal Medicine 241(5). p.379-385
- Contribution to journal › Article
Mark The 20210 A allele of the prothrombin gene is a common risk factor among Swedish outpatients with verified deep venous thrombosis
Hillarp, Andreas ^LU ; Zöller, Bengt ^LU ; Svensson, Peter ^LU and Dahlbäck, Björn ^LU (1997) In Thrombosis and Haemostasis 78(3). p.2-990
- Contribution to journal › Debate/Note/Editorial

your query:: Remove department: Clinical Coagulation, Malmö